Androgenetic Alopecia

Also known as: Male Pattern Baldness / Alopecia, Androgenetic / Androgenic Alopecia / Common baldness

DrugDrug NameDrug Description
DB01216FinasterideAn antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase.
DB00350MinoxidilAn antihypertensive vasodilating agent used for resistant hypertension that is symptomatic or has caused end organ damage.
DrugDrug NamePhaseStatusCount
DB00905Bimatoprost1Completed2
DB00905Bimatoprost1Terminated1
DB01126Dutasteride1Recruiting1
DB01216Finasteride1Completed2
DB00350Minoxidil1 / 2Completed1
DB00905Bimatoprost2Completed3
DB12499Clascoterone2Completed1
DB00350Minoxidil2Completed3
DB00350Minoxidil2Recruiting1
DB00313Valproic acid2Completed1
DB01126Dutasteride3Completed2
DB01216Finasteride3Completed4
DB00350Minoxidil3Active Not Recruiting1
DB00350Minoxidil3Completed4
DB00350Minoxidil4Recruiting1
DB00350MinoxidilNot AvailableCompleted2
DB00350MinoxidilNot AvailableWithdrawn1